Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aerovate Therapeutics, Inc.

9.80
+0.0000
Volume:- -
Turnover:- -
Market Cap:284.05M
PE:-5.76
High:9.80
Open:9.80
Low:9.80
Close:9.80
Loading ...
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 27, 2024

Major Issues Report

Form 8-K - Current report
Mar 25, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Mar 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities